On February 21st, the UNED received as a new Doctor Honoris Causa the Spanish scientist Dr. Mariano Barbacid Motalbán, one of the world’s leading experts in cancer, at the proposal of the International Doctoral School.

The award recognizes his outstanding merits in basic research on the mechanisms underlying different types of tumors.

The academic ceremony took place at 11.30 a.m. in the auditorium of the Humanities building. The rector of the UNED, Ricardo Mairal Usón presided over the solemn ceremony accompanied by the second vice-president of the Social Council of the UNED, Aurelio López de Hita, and by the general secretary of the UNED, Rebeca de Juan Díaz.

Dr. Barbacid received the investiture accompanied and presented by his two sponsors, the vice-rector for Research, Knowledge Transfer and Scientific Dissemination of the UNED, Rosa María Martín Aranda; and the director of the Carlos III Institute of Health, Cristóbal Belda Iniesta, who pronounced the respective laudations to the career of the new doctor honoris causa.

Dr. Mariano Barbacid responded to them with his acceptance speech at the UNED. We are witnessing a series of events that are allowing me to see how the work carried out four decades ago is beginning to bear fruit,” he said. “Better late than never. Fortunately, my research work does not live only on past satisfactions. The present is as promising as my first five decades as a researcher.”

Dr. Mariano Barbacid is a professor of the Molecular Oncology Master. According to Cristóbal Belda, “without this training, the arm of knowledge generated in multiple translational science laboratories, our ability to understand what is happening today with drugs directed against molecular targets would be more than limited and, consequently, the impact of contemporary oncology would be very limited. He has made science accessible to those of us who have the obligation to apply it to our fellow human beings”.

The investiture ceremony was attended by Dr. Mónica López Barahona, Director General of the CEB, together with Dr. Alberto Muñoz Terol, Director of the first module of the Molecular Oncology Master (MOM).